Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study

Journal of Infection and Chemotherapy - Tập 28 - Trang 10-18 - 2022
Thuy Ngan Tran1, Dinh Hoa Vu2, Hoang Anh Nguyen2,3, Steven Abrams1,4, Robin Bruyndonckx4,5, Thi Tuyen Nguyen2, Nhat Minh Tran2, The Anh Trinh6, Thi Hong Gam Do3, Hong Nhung Pham7, Gia Binh Nguyen6, Samuel Coenen1,5
1Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium
2National Centre of Drug Information and Adverse Drug Reactions Monitoring, Hanoi University of Pharmacy, Hanoi, Viet Nam
3Department of Pharmacy, Bach Mai Hospital, Hanoi, Viet Nam
4Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Data Science Institute (DSI), Hasselt University, Hasselt, Belgium
5Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium
6Intensive Care Unit, Bach Mai Hospital, Hanoi, Viet Nam
7Department of Microbiology, Bach Mai Hospital, Hanoi, Viet Nam

Tài liệu tham khảo

World Health Organization, 2017 Ramos-Castaneda, 2018, Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections, J Infect, 76, 438, 10.1016/j.jinf.2018.02.007 Effah, 2020, Klebsiella pneumoniae: an increasing threat to public health, Ann Clin Microbiol Antimicrob, 19, 1, 10.1186/s12941-019-0343-8 Pham, 2018, J Clin Med, 101, 43 Pirracchio, 2015, Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study, Lancet Respir Med, 3, 42, 10.1016/S2213-2600(14)70239-5 Awad, 2020, Predicting hospital mortality for intensive care unit patients: time-series analysis, Health Inf J, 26, 1043, 10.1177/1460458219850323 Chang, 2020, Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: clinical impact of carbapenem resistance in a large tertiary hospital of China, J Infect Public Health, 13, 784, 10.1016/j.jiph.2019.11.014 2017 Tumbarello, 2015, Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study, J Antimicrob Chemother, 70, 2133, 10.1093/jac/dkv086 Tofas, 2016, Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: analysis of 50 cases, Int J Antimicrob Agents, 47, 335, 10.1016/j.ijantimicag.2016.01.011 Seo, 2020, Clinical and microbiological analysis of risk factors for mortality in patients with carbapenem-resistant Enterobacteriaceae bacteremia, Int J Antimicrob Agents, 56, 106126, 10.1016/j.ijantimicag.2020.106126 Giannella, 2018, Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection, Int J Antimicrob Agents, 51, 244, 10.1016/j.ijantimicag.2017.08.019 Xiao, 2018, A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality, Infect Drug Resist, 11, 595, 10.2147/IDR.S153246 Walton, 2016, Improving hospital death certification in Viet Nam: results of a pilot study implementing an adapted WHO hospital death report form in two national hospitals, BMJ Glob Health, 1, 10.1136/bmjgh-2015-000014 Cristina, 2018, Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area, J Infect Public Health, 11, 171, 10.1016/j.jiph.2017.06.003 Kontopidou, 2014, Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options, Clin Microbiol Infect, 20, O117, 10.1111/1469-0691.12341 Neuner, 2011, Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections, Diagn Microbiol Infect Dis, 69, 357, 10.1016/j.diagmicrobio.2010.10.013 Xu, 2018, Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome, BMC Infect Dis, 18, 358, 10.1186/s12879-018-3263-x Wang, 2019, Epidemiologic analysis and control strategy of Klebsiella pneumoniae infection in intensive care units in a teaching hospital of People's Republic of China, Infect Drug Resist, 12, 391, 10.2147/IDR.S189154 Ben-David, 2012, Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections, Clin Microbiol Infect, 18, 54, 10.1111/j.1469-0691.2011.03478.x Stavem, 2017, Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patients, Clin Epidemiol, 9, 311, 10.2147/CLEP.S133624 Singer, 2016, The Third international Consensus Definitions for Sepsis and septic shock (Sepsis-3), J Am Med Assoc, 315, 801, 10.1001/jama.2016.0287 Xu, 2017, Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae, Ann Clin Microbiol Antimicrob, 16, 18, 10.1186/s12941-017-0191-3 Durdu, 2016, Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection, SpringerPlus, 5, 1892, 10.1186/s40064-016-3580-8 Man, 2017, Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong, J Hosp Infect, 97, 35, 10.1016/j.jhin.2017.06.007 Kohler, 2017, Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis, Infect Control Hosp Epidemiol, 38, 1319, 10.1017/ice.2017.197 Kim, 2019, Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection, J Antimicrob Chemother, 74, 190 Patel, 2008, Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies, Infect Control Hosp Epidemiol, 29, 1099, 10.1086/592412 Little, 1988, A test of missing completely at random for multivariate data with missing values, J Am Stat Assoc, 83, 10.1080/01621459.1988.10478722 Kim, 2002, Tests of homogeneity of means and covariance matrices for multivariate incomplete data, Psychometrika, 67, 609, 10.1007/BF02295134 Hewett, 2012, Assessment of SOFA score as a diagnostic indicator in intensive care medicine, IFAC Proceedings Volumes, 45, 467, 10.3182/20120829-3-HU-2029.00035 Ferreira, 2001, Serial evaluation of the SOFA score to predict outcome in critically ill patients, J Am Med Assoc, 286, 1754, 10.1001/jama.286.14.1754 Grobbee, 2015 Shipe, 2019, Developing prediction models for clinical use using logistic regression: an overview, J Thorac Dis, 11, S574, 10.21037/jtd.2019.01.25 R Core Team, 2019 Moons, 2015, Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration, Ann Intern Med, 162, W1, 10.7326/M14-0698 Moons, 2002, Should scoring rules be based on odds ratios or regression coefficients?, J Clin Epidemiol, 55, 1054, 10.1016/S0895-4356(02)00453-5 Minne, 2008, Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review, Crit Care, 12, R161, 10.1186/cc7160 Kelley, 2018 Baigelman, 1983, Patient readmission to critical care units during the same hospitalization at a community teaching hospital, Intensive Care Med, 9, 253, 10.1007/BF01691250 Durbin, 1993, A case-control study of patients readmitted to the intensive care unit, Crit Care Med, 21, 1547, 10.1097/00003246-199310000-00025 Khajehali, 2021, The prediction of mortality influential variables in an intensive care unit: a case study, Personal Ubiquitous Comput, 10.1007/s00779-021-01540-5